Miriam Adam

Hebrew University of Jerusalem

Papers

3

Total Citations

463

H-Index

3

About

Miriam Adam is a biomedical researcher whose work spans systems biology, genomics, and infectious disease diagnostics. She made a significant contribution to the field of systems-level biology through her involvement in the NIH LINCS (Library of Integrated Network-Based Cellular Signatures) program, a landmark initiative aimed at cataloging how human cells respond to various perturbations at a molecular level. This 2017 publication has garnered an impressive 447 citations, underscoring its foundational importance to the research community and its role in advancing our understanding of cellular signaling networks. Adam's research portfolio also reflects her rapid responsiveness to emerging public health crises. During the COVID-19 pandemic, she contributed innovative approaches to SARS-CoV-2 diagnostics, developing extraction-free and early-pooling protocols — ApharSeq and a sample tagging and pooling method — designed to dramatically scale up testing capacity while reducing costs and logistical bottlenecks. These methodologies addressed critical bottlenecks in global testing infrastructure at a time of urgent need. Taken together, Adam's work demonstrates a versatile scientific profile, bridging large-scale cellular biology initiatives with pragmatic, high-impact solutions in molecular diagnostics, making her a valuable contributor to both basic and applied biomedical research.

Research Focus

Key Achievements

3
H-Index
3
Papers
463
Total Citations
154
Avg Citations/Paper
🏆 Most Cited Paper
The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations
447 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 115
🏛 Institutions: Hebrew University of Jerusalem

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago